Alopecia Totalis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
Conditions:   Alopecia Universalis (AU);   Alopecia Totalis (AT) Interventions:   Drug: Vehicle;   Drug: ATI-50002 Sponsor:   Aclaris Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2017 Category: Research Source Type: clinical trials